Avai Bio, Inc.
AVAI· OTC
Filed Oct 15, 2019 · 10-Q · 107 days after period end · 0001740797-19-000024
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Net Income | -$14.70K | -$6.20K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Oct 15, 2019 · 107 d after period end